Basic information Safety Supplier Related

HIRUDIN

Basic information Safety Supplier Related

HIRUDIN Basic information

Product Name:
HIRUDIN
Synonyms:
  • hirudex
  • recombinanthirudin
  • HIRUDIN RECOMBINANT
  • DESULFATO-HIRUDIN
  • DESULFO-HIRUDIN
  • NATIVE HIRUDIN
  • [TYR63]HIRUDIN (HV1), LEECH
  • (63-tyrosine)hirudin (hv1),leech,rec. F. yeast
CAS:
8001-27-2
MF:
C287H440N80O113S7
MW:
7043.4877
EINECS:
232-279-1
Product Categories:
  • Coagulation Proteins and ReagentsPlasma&Blood Proteins
  • HirudinProtease Inhibitors
  • Plasma&Blood Proteins
  • Plasma, Blood, and Related Proteins and Reagents
  • Protease Inhibitor Specificity Index
  • Proteins and Derivatives
  • R to
  • Thrombin
  • ThrombinEnzyme Inhibitors by Enzyme
  • proteins
Mol File:
8001-27-2.mol
More
Less

HIRUDIN Chemical Properties

storage temp. 
2-8°C
form 
lyophilized powder
color 
white
Merck 
13,4737
More
Less

Safety Information

Safety Statements 
22-24/25
WGK Germany 
3
RTECS 
MR8440000
10-21
HS Code 
3504009000

MSDS

More
Less

HIRUDIN Usage And Synthesis

Description

Refludan was launched in Germany for heparin-associated thrombocytopenia. Originally isolated from the saliva of leeches (Hirudo medicinalis), the gene for recombinant hirudin was synthesized and expressed in Saccharomyces cerevisiae. The isolated protein is 65 amino acids differing from the native protein by the first two amino acids (Leu1 and Thr2) and Tyr63 is not sulfated, while it does retain the three disulfide bonds. Refludan is a potent, specific and almost irreversible inhibitor of thrombin with which it forms a 1:1 complex. The N-terminal domain binds to the active catalytic site of thrombin, while the C-terminal end binds to the anion binding exosite (fibrinogen binding cleft). It has several advantages over heparin: it can inhibit thrombin bound to extracellular matrices, does not require antithrombin Ⅲ as a cofactor, is not inhibited by activated platelet nor increases platelet activity, and is a pure, single compound with a single mechanism of action. It is useful for myocardial infarcts, unstable angia and cardiovascular events. Heparin treatment can be inhibited by platelets activated by the Fc fragment of antibodies developed to the antigen of heparin-platelet factor 4. A corresponding inactivation of Refuldan is not known.

Originator

Hoechst Merion Roussel (Germany)

Uses

Recombinant hirudin from yeast has been used in mannan-binding lectin serine protease 2 (MASP2) activation assay. It has also been used in pre-treating the nanosheets in phosphate buffered saline (PBS) for platelet adhesion assay.

brand name

Refludan

General Description

Hirudin is a 7 kDa acidic protein containing 65 amino acid residues that has an isoelectric point of 3.5-4.0. It is not glycosylated and lacks tryptophan, arginine and methionine residues. It is chemically stable between pH 2-12 and at temperatures up to 80°C.

Biochem/physiol Actions

The anticoagulant, hirudin, is the most potent natural inhibitor of both soluble and clot-bound thrombin. It forms a high-affinity 1:1 complex with thrombin, occluding both the proteolytic site and exosite I (fibrinogen and PAR recognition site). Hirudin blocks thrombus growth and platelet activation, and has been suggested as the clinically preferred anticoagulant (over heparin and citrate) for its specific mode of action and absence of side effects. It is not metabolized in the bloodstream of humans and is eliminated unchanged via kidney filtration.

HIRUDINSupplier

LGM Pharma
Tel
1-(800)-881-8210
Email
inquiries@lgmpharma.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Wuhan DKY Technology Co.,Ltd.
Tel
27-81302488 18007166089
Email
info@dkybpc.com
Wuxi Zhongkun Biochemical Technology Co., Ltd.
Tel
0510-85629785 18013409632
Email
sales@reading-chemicals.com
Hubei Jusheng Technology Co.,Ltd
Tel
027-59599241 18871490274
Email
1400878000@qq.com